Hyperbranched Poly(citric acid) Mitigated Iron Overload Damage via Iron Chelation and Antioxidation

Area of Science:

• Biomaterials Science
• Toxicology
• Biochemistry

Background:

• Iron overload (IO) leads to pathological organ damage.
• Current treatments like iron chelators have toxic side effects, and antioxidants are ineffective at reducing iron deposition.

Purpose of the Study:

• To synthesize a biodegradable hyperbranched poly(citric acid) (PCA).
• To investigate the therapeutic effects of PCA on iron overload-induced liver and bone injuries in mouse models.

Main Methods:

• Synthesis of biodegradable hyperbranched poly(citric acid) (PCA).
• Evaluation of PCA's iron chelation capabilities.
• Assessment of PCA's effects on apoptosis, ROS production, and mitochondrial dysfunction in vitro.
• Investigation of PCA's efficacy in mouse models of bone loss and liver injury.

Main Results:

• PCA demonstrated significant iron chelation abilities.
• PCA inhibited iron overload-induced apoptosis, ROS production, and mitochondrial dysfunction.
• PCA reduced iron deposition in bones, improving tissue morphology and microstructure.
• PCA mitigated oxidative stress, thereby reducing liver injury.

Conclusions:

• PCA shows promise as a therapeutic agent for iron overload disorders.
• PCA effectively reduces iron deposition and ameliorates associated organ damage.
• PCA offers a potentially safer and more effective treatment strategy compared to existing therapies.